Skip to main content

Table 1 Patients’ characteristics

From: Evaluation of NAFLD and fibrosis in obese patients – a comparison of histological and clinical scoring systems

Demographic data

 Male

38

27%

 Female

103

73%

 Age (years)

44

± 9

 BMI (kg/m2)

53

± 7

Comorbidities

 Type 2 diabetes mellitus

50

35%

 Arterial hypertension

86

61%

 Obstructive sleep apnea syndrome

58

41%

NAFLD Activity Score (NAS)

 Not NASH

49

35%

 Borderline

65

46%

 Definite NASH

27

19%

Steatosis-activity-fibrosis (SAF) Score

  

 No NAFLD

24

17%

 NAFLD

59

42%

 NASH

58

41%